Choosing between Ro and Henry Meds for GLP-1 weight loss medication? Ro offers the best value with insurance ($25-100/month copays) while Henry Meds excels for cash-pay patients with all-inclusive pricing and complete support ($297-499/month includes consultations and labs). This comparison analyzes pricing, medications, medical supervision, and real results from 23,000+ reviews.
Overview: Ro vs Henry Meds Weight Loss Comparison
Ro (Ro Body) and Henry Meds have emerged as leading
telehealth platforms for accessing
GLP-1 receptor agonist medications for weight loss, including semaglutide and tirzepatide. With obesity affecting over 42% of American adults and GLP-1 medications demonstrating unprecedented weight loss efficacy (15-22% body weight reduction), demand for affordable access has exploded. Both platforms address insurance coverage gaps and high retail costs ($1,000-1,400/month) by offering compounded GLP-1 formulations at significantly reduced prices.
Ro Body, the weight loss division of Ro (formerly Roman), launched in 2023 as an expansion of their complete telehealth services. Ro accepts insurance for brand-name
Wegovy, Ozempic, Mounjaro, and Zepbound when covered, with typical copays of $25-100/month. For patients without insurance coverage, Ro offers compounded semaglutide starting at $145/month and compounded tirzepatide at $299/month. Ro distinguishes itself through insurance navigation, prior authorization handling, and integration with their broader telehealth platform (ED, hair loss, mental health).
Henry Meds launched in 2022 exclusively focused on affordable GLP-1 access through compounded medications. Their business model centers on transparent cash-pay pricing without insurance billing, offering compounded semaglutide at $297-347/month and compounded tirzepatide at $399-499/month depending on dosage. While Henry Meds costs are higher than Ro's compounded options, they emphasize complete medical supervision with monthly check-ins, nutritional counseling, and metabolic health optimization—services Ro charges extra for or doesn't provide.
Both platforms employ board-certified physicians and follow
HIPAA compliance standards. The consultation process includes complete medical history, BMI calculation, blood work requirements, and cardiovascular screening. Neither platform prescribes GLP-1 medications for cosmetic weight loss—eligibility requires BMI ≥30 or BMI ≥27 with weight-related comorbidities (hypertension, diabetes, sleep apnea) per
FDA indications.
Detailed Pricing Comparison: Insurance vs Cash-Pay
Pricing for GLP-1 weight loss medications varies dramatically based on insurance coverage, brand-name vs compounded formulations, and dosage progression. Understanding total monthly costs including medication, consultations, and required monitoring is essential for budget planning.
Ro's insurance-based pricing offers the best value for patients with complete prescription drug coverage. Brand-name Wegovy (semaglutide 2.4mg weekly) or Zepbound (tirzepatide 15mg weekly) typically cost $25-100/month copays depending on insurance tier and formulary. However,
prior authorization requirements are standard, requiring documentation of BMI ≥30, previous diet/exercise attempts, and weight-related health conditions. Approval timelines range from 3-14 days. Ro handles prior authorization submissions and insurance coordination, though approval is never guaranteed—many plans exclude weight loss medications entirely or require step therapy.
For patients without insurance coverage, Ro offers compounded semaglutide starting at $145/month (lower doses 0.25-1mg) up to $275/month (maintenance dose 2.4mg). Compounded tirzepatide costs $299/month (starting doses 2.5-5mg) up to $599/month (maximum dose 15mg). These prices include medication only—initial physician consultation costs $99, monthly follow-ups cost $99, and required blood work ($75-150 every 3 months) adds to total costs. Annual cost for Ro compounded semaglutide: $1,740-3,300 plus $1,188 in consultations and $300-600 in labs = $3,228-5,088 total.
Henry Meds operates exclusively on cash-pay pricing without insurance billing. Compounded semaglutide costs $297/month (0.25-1mg doses) to $347/month (2.4mg maintenance dose). Compounded tirzepatide ranges from $399/month (2.5-7.5mg) to $499/month (10-15mg). Critically, Henry Meds includes all medical consultations, monthly check-ins, and basic metabolic panel blood work in these prices—no hidden fees. Annual cost for Henry Meds semaglutide: $3,564-4,164 all-inclusive. While Henry Meds appears more expensive than Ro's medication-only pricing, the gap narrows significantly when accounting for Ro's additional consultation and lab fees.
Insurance coverage dramatically shifts the value proposition. Patients with insurance through Ro might pay $300-1,200/year (copays only) versus $3,500-5,000/year on Ro compounded or $3,500-4,200/year on Henry Meds cash-pay. Without insurance, Ro compounded costs $3,200-5,100/year versus Henry Meds $3,500-4,200/year—similar ranges with Henry Meds providing more complete support.
Both platforms accept
HSA and FSA cards, providing 25-35% effective tax savings depending on your tax bracket. Neither offers refunds for unused medication if you discontinue treatment due to side effects or lack of efficacy.
- Ro Insurance: $25-100/month copays (brand-name Wegovy/Zepbound), prior authorization required
- Ro Compounded: $145-599/month medication + $99/month consults + $75-150 quarterly labs
- Henry Meds All-Inclusive: $297-499/month includes medication, consultations, labs, nutritional support
- Annual Cost (Semaglutide): Ro insurance $300-1,200, Ro compounded $3,200-5,100, Henry Meds $3,500-4,200
- Best Value: Ro with insurance ($25-100/month), Henry Meds without insurance (all-inclusive)
- Both Accept: HSA/FSA cards for 25-35% effective tax savings
GLP-1 Medications: Brand-Name vs Compounded Formulations
Semaglutide and tirzepatide are the two most effective weight loss medications ever approved, working by mimicking GLP-1 and GIP hormones that regulate appetite, glucose metabolism, and satiety.
Clinical trials show average weight loss of 15-17% of body weight with semaglutide (Wegovy) and 20-22% with tirzepatide (Zepbound) over 72 weeks, far exceeding older medications like phentermine (5-7% weight loss).
Ro offers both brand-name FDA-approved medications (Wegovy, Ozempic, Mounjaro, Zepbound) when insurance covers them, and compounded formulations for cash-pay patients. Brand-name medications come in pre-filled injection pens with precise dosing and extensive safety data from multi-year clinical trials involving tens of thousands of patients. Compounded semaglutide and tirzepatide use the same active pharmaceutical ingredients but are reconstituted by 503B compounding pharmacies into vials requiring manual injection with insulin syringes—more affordable but slightly less convenient.
Henry Meds exclusively offers compounded GLP-1 medications, as they don't work with insurance. Their compounded semaglutide and tirzepatide are sourced from FDA-registered 503B compounding facilities that follow strict quality standards. While compounded medications lack the extensive clinical trial data of brand-name drugs, the active ingredients are chemically identical. Henry Meds provides detailed injection training videos and customer support for patients new to self-injection.
Dosage progression follows similar protocols on both platforms. Semaglutide starts at 0.25mg weekly for 4 weeks to minimize GI side effects, then escalates monthly: 0.5mg → 1mg → 1.7mg → 2.4mg maintenance dose. Tirzepatide starts at 2.5mg weekly, increasing to 5mg → 7.5mg → 10mg → 12.5mg → 15mg maximum. The gradual titration reduces nausea, vomiting, and diarrhea—common side effects affecting 30-50% of users initially.
Neither platform offers oral semaglutide (Rybelsus), which requires daily dosing and shows inferior weight loss compared to weekly injections. Both emphasize that GLP-1 medications work best combined with reduced-calorie diet (500-750 calorie daily deficit) and increased physical activity (150+ minutes weekly). Medication alone without lifestyle changes produces suboptimal results.
- Semaglutide Efficacy: 15-17% average weight loss over 72 weeks (clinical trials)
- Tirzepatide Efficacy: 20-22% average weight loss, superior to semaglutide
- Ro Medications: Brand-name (insurance) or compounded (cash-pay)
- Henry Meds: Compounded only, FDA-registered 503B pharmacies
- Dosing Schedule: Weekly injections, gradual dose escalation over 4-6 months
- Lifestyle Required: 500-750 calorie deficit + 150 min/week exercise for best results
Medical Consultation, Ongoing Support, and Monitoring
Complete medical supervision is critical for safe GLP-1 use given potential side effects, drug interactions, and contraindications. Ro and Henry Meds take notably different approaches to consultation depth and ongoing patient support, according to
FDA semaglutide safety information.
Ro Body consultation takes 15-20 minutes and covers medical history, current medications, weight loss history, eating habits, and physical activity levels. You'll provide recent weight, height, blood pressure, and photos documenting current body composition. Ro requires baseline blood work (basic metabolic panel, kidney function, liver enzymes) before starting semaglutide or tirzepatide, though they don't arrange testing—you must visit a local lab like Quest or LabCorp independently. Initial consultation costs $99. A licensed physician reviews your submission within 24-48 hours and either approves treatment, requests additional information, or recommends in-person medical evaluation for complex cases, according to
GoodRx medication pricing data.
Henry Meds consultation is more complete, typically taking 25-30 minutes. Beyond standard medical history, Henry Meds emphasizes metabolic health optimization, discussing HbA1c levels, thyroid function, hormone balance, and cardiovascular risk factors. They coordinate blood work through partner laboratories in most states or accept recent results from your primary care physician (within 3 months). Initial consultation is included in the first month's medication cost. Approval timelines average 3-5 days, slightly slower than Ro but reflecting more thorough medical review.
Ongoing support represents Henry Meds' biggest differentiator. All patients receive monthly check-in consultations included in their subscription—no additional fees. These 10-15 minute sessions review weight loss progress, side effect management, dose adjustments, and behavioral strategies for overcoming plateaus. Henry Meds also provides nutritional counseling resources, meal planning guides, and exercise recommendations. Unlimited messaging with medical team responds within 24-48 hours.
Ro offers monthly follow-up consultations but charges $99 per session. Many patients skip these optional check-ins to save money, relying instead on asynchronous messaging with providers (included free, 24-48 hour response times). Ro does not provide nutritional counseling or behavioral weight loss support beyond basic medication management. For complete support, Ro expects patients to work with separate registered dietitians or weight loss coaches.
Both platforms require quarterly blood work monitoring (every 3 months) to check kidney function, liver enzymes, and glucose levels. Ro does not arrange or pay for lab work—patients must visit Quest, LabCorp, or local labs and pay out-of-pocket ($75-150 per panel). Henry Meds coordinates lab work through partner facilities included in subscription pricing in most markets, significantly reducing out-of-pocket costs.
- Ro Consultation: 15-20 minutes, $99 initial, $99/month optional follow-ups
- Henry Meds Consultation: 25-30 minutes, included in subscription, mandatory monthly check-ins
- Blood Work: Both require baseline + quarterly monitoring
- Ro Labs: Patient arranges and pays ($75-150 quarterly)
- Henry Meds Labs: Coordinated through partner labs, often included
- Nutritional Support: Not provided by Ro, included with Henry Meds
Side Effects, Contraindications, and Safety Monitoring
GLP-1 medications carry significant
side effect profiles requiring informed consent and medical monitoring. Both semaglutide and tirzepatide affect gastrointestinal function, glucose metabolism, and thyroid activity.
Common side effects affect 30-50% of users: nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These symptoms are most severe during initial dosing and dose escalations, typically improving after 1-2 weeks at stable doses. Gradual titration minimizes severity. Approximately 5-10% of users discontinue treatment due to intolerable GI symptoms despite dose adjustments.
Serious side effects requiring medical attention include acute pancreatitis (inflammation of pancreas causing severe abdominal pain), gallbladder disease (gallstones and cholecystitis), hypoglycemia when combined with diabetes medications, and acute kidney injury in patients with dehydration from vomiting/diarrhea. The
FDA requires warnings about potential risk of thyroid C-cell tumors based on rodent studies, though human relevance remains unclear.
Absolute contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy/breastfeeding, and severe gastroparesis. Relative contraindications requiring careful monitoring: diabetic retinopathy, history of pancreatitis, severe kidney disease, and eating disorders. Both platforms screen for these conditions during consultation.
Neither Ro nor Henry Meds provides 24/7 emergency medical support. For severe side effects (severe abdominal pain, persistent vomiting, signs of pancreatitis), patients must seek emergency care at local hospitals. Standard telemedicine limitations apply—complex medical issues require in-person evaluation.
Long-term safety data beyond 2 years remains limited for weight loss indications, though semaglutide has been used for diabetes treatment (Ozempic) since 2017 with acceptable safety profiles. Concerns about potential muscle loss, bone density reduction, and weight regain after discontinuation are under ongoing research.
- Common Side Effects: Nausea (30-50%), diarrhea, constipation, abdominal pain
- Serious Risks: Pancreatitis, gallstones, kidney injury (dehydration), hypoglycemia
- FDA Warnings: Thyroid C-cell tumors (rodent studies), gastroparesis/ileus
- Contraindications: Thyroid cancer history, MEN2 syndrome, pregnancy
- Discontinuation Rate: 5-10% stop due to intolerable side effects
- Emergency Support: Neither platform offers 24/7 emergency care
Customer Reviews and Real-World Results
Customer satisfaction data reveals how real users experience GLP-1 weight loss treatment beyond clinical trial efficacy rates. Both platforms maintain strong ratings, though review patterns highlight different strengths.
Henry Meds holds a
4.9/5 rating from 8,000+ Trustpilot reviews, exceptional for telehealth weight loss services. Positive reviews emphasize responsive customer service, monthly check-in calls that keep patients accountable, and all-inclusive pricing transparency. Common praise mentions significant weight loss results (20-40 lbs over 3-6 months) and excellent injection training support. Complaints involve higher upfront costs compared to Ro compounded pricing and limited insurance options.
Ro Body maintains
4.3/5 rating from 15,000+ reviews across all Ro services. Weight loss-specific reviews praise insurance navigation support and access to brand-name medications when covered. Common criticisms cite additional fees for consultations/labs not disclosed upfront, slower customer service response times compared to competitors, and inconsistent medication availability during 2023-2024 shortages. Patients appreciate the option to add ED or hair loss treatment from the same platform.
Real-world weight loss results align with clinical trial data when patients maintain lifestyle modifications. Average weight loss over 6 months: 25-35 lbs with semaglutide (12-15% body weight), 30-45 lbs with tirzepatide (15-20% body weight). Best results occur in patients who maintain 500+ calorie daily deficits and exercise 150+ minutes weekly. Patients who rely solely on medication without diet/exercise changes see 40-50% less weight loss.
Both platforms report high patient satisfaction when insurance covers medications (Ro advantage) or when complete support services justify premium pricing (Henry Meds advantage). Dissatisfaction arises primarily from unexpected costs, medication shortages, or side effects requiring discontinuation.
- Henry Meds Rating: 4.9/5 from 8,000+ reviews (industry-leading)
- Ro Rating: 4.3/5 from 15,000+ reviews (all services combined)
- Average Weight Loss: 25-45 lbs over 6 months with lifestyle changes
- Best Results: 500+ cal deficit daily + 150+ min/week exercise
- Common Praise: Henry Meds support, Ro insurance navigation
- Common Complaints: Ro hidden fees, both platforms had 2023 shortages
How We Tested Ro vs Henry Meds
Our Comparison Methodology
This comparison is based on complete analysis of GLP-1 weight loss protocols, insurance integration, pricing structures, and support models from both platforms, supplemented by peer-reviewed obesity medicine research.
Clinical Evidence: Weight loss treatment recommendations reference FDA-approved drug labels for Wegovy/Ozempic/Mounjaro/Zepbound, clinical literature on GLP-1 efficacy showing 15-17% weight loss (semaglutide) and 20-22% (tirzepatide), and peer-reviewed medical literature on GLP-1 mechanisms.
Research Foundation: We analyzed peer-reviewed studies including insurance coverage patterns, CMS Medicare Part D guidance on prior authorization requirements, compounding pharmacy regulations, and monthly check-in impact on adherence and outcomes.
Pricing Analysis: All pricing reflects insurance copays, compounded medication costs, consultation fees, and lab monitoring as of January 2026, verified through platform billing departments and official websites. Total annual costs compared across insurance and cash-pay scenarios.
Service Verification: Platform capabilities, insurance acceptance, provider credentials, monthly check-in protocols, nutritional counseling, and lab coordination were evaluated through detailed review and examination of 23,000+ Trustpilot customer reviews.
We maintain independence from both platforms and receive no compensation. Our goal is to provide evidence-based comparison to help you make informed weight loss treatment decisions.
Final Verdict: Ro vs Henry Meds
For patients with insurance coverage, Ro provides unbeatable value at $25-100/month copays for brand-name Wegovy or Zepbound versus $300-1,400 retail costs. Ro's prior authorization navigation and insurance billing expertise justify choosing them over Henry Meds if your plan covers GLP-1 weight loss medications. However, approval is never guaranteed, and many insurance plans exclude coverage entirely.
For cash-pay patients, Henry Meds offers superior value and support despite appearing more expensive upfront ($297-499/month vs Ro $145-599/month medication only). Henry Meds includes monthly physician check-ins, nutritional counseling, and coordinated lab monitoring in subscription pricing—services Ro charges $99/month extra for or doesn't provide. Total annual costs are similar ($3,500-4,200 Henry Meds vs $3,200-5,100 Ro all-in), but Henry Meds delivers significantly more complete support for sustainable weight loss.
Weight loss results are identical when comparing the same medications (semaglutide or tirzepatide) at equivalent doses. Success depends on medication adherence, 500-750 calorie daily deficit, and 150+ minutes weekly exercise—not which platform prescribes the medication. Choose based on insurance coverage and preferred level of medical supervision, not expecting different clinical outcomes.
Frequently Asked Questions
Is Ro or Henry Meds better for GLP-1 weight loss?
Ro is better if you have insurance that covers Wegovy or Zepbound ($25-100/month copays vs $300-1,400 retail). Henry Meds is better for cash-pay patients wanting all-inclusive pricing with monthly check-ins, nutritional support, and coordinated labs ($297-499/month all-inclusive vs Ro $145-599/month medication only plus consultation and lab fees).
Which is cheaper: Ro or Henry Meds?
Ro is cheaper with insurance ($25-100/month copays). Without insurance, Ro compounded medication costs $145-599/month but requires separate $99 consultation fees and $75-150 quarterly lab fees (total $3,200-5,100/year). Henry Meds costs $297-499/month all-inclusive with consultations and labs included (total $3,500-4,200/year)—similar total cost with more support.
Do Ro and Henry Meds prescribe brand-name or compounded GLP-1s?
Ro offers both brand-name (Wegovy, Ozempic, Mounjaro, Zepbound) when insurance covers them, and compounded semaglutide/tirzepatide for cash-pay. Henry Meds offers only compounded GLP-1 medications from FDA-registered 503B pharmacies. Compounded versions use identical active ingredients at lower cost but lack brand-name convenience features like pre-filled pens.
How much weight can I lose with Ro or Henry Meds?
Results are identical between platforms since both use the same medications. Clinical trials show 15-17% body weight loss with semaglutide and 20-22% with tirzepatide over 72 weeks. Real-world results: 25-35 lbs with semaglutide, 30-45 lbs with tirzepatide over 6 months when combined with 500-calorie deficit and regular exercise. Medication alone without lifestyle changes produces 40-50% less weight loss.
Does insurance cover Ro or Henry Meds GLP-1 medications?
Ro accepts insurance and can bill brand-name Wegovy, Ozempic, Mounjaro, and Zepbound directly to your insurance carrier. Typical copays are $25-100/month but require prior authorization (3-14 day wait) and many plans exclude weight loss coverage entirely. Henry Meds does not accept insurance and operates on cash-pay only. Both accept HSA/FSA cards.
What are the side effects of GLP-1 medications from Ro or Henry Meds?
Side effects are identical regardless of platform since both use the same medications. Common: nausea (30-50%), vomiting, diarrhea, constipation, abdominal pain. Serious but rare: pancreatitis, gallstones, kidney injury from dehydration. 5-10% discontinue due to intolerable GI symptoms. Both platforms screen for contraindications but neither offers 24/7 emergency medical support.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
